Skip to content

Factors Influencing Cardiovascular Prognosis

Factors Influencing Cardiovascular Prognosis in Hypertensive Patients (Pythia Study)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00973206
Acronym
Pythia-GR
Enrollment
5000
Registered
2009-09-09
Start date
2017-01-31
Completion date
2027-01-31
Last updated
2014-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Mortality

Keywords

cardiovascular morbidity, mortality community study

Brief summary

The purpose of this study is to identify risks for cardiovascular events in a follow up period of 10 years.

Detailed description

Inclusion criteria * Age \> 50 years volunteers (2 towns of 15000 residents one in the north and one in the south of Greece) * End points * 5-10 years cardiovascular morbidity and mortality Measurements at baseline * Anthropometrics * Age (M\>55 years; W\>65 years) * Weight-height- BMI * Abdominal obesity (Waist circumference\>102 cm(M), \>88cm (W) Family history * Family history of premature CV disease (M at age\<55 years; W at age\<65 years) History * Smoking * Diabetes Mellitus, * Established Heart disease: myocardial infarction; angina; coronary revascularization; heart failure * Established renal disease \[diabetic nephropathy; renal impairment (serum creatinine M\>133, W\>124 mmol/l); proteinuria (\> 300 mg/24 h)\] * Cerebrovascular disease: ischaemic stroke; cerebral haemorrhage; transient ischaemic attack * Peripheral artery disease * Advanced retinopathy: haemorrhages or exudates, papilloedema * Treatment Measurements * Measurements Blood pressure * Clinic BP * 24h ABPM * Home BP Heart * Electrocardiographic LVH * Echocardiographic LVH Vessels * Carotid wall thickening or plaque * Carotid-femoral pulse wave velocity * Ankle/brachial BP index Lipids or other risk factors * Total cholesterol, Tg, HDL, LDL * Plasma creatinine, estimated glomerular filtration rate * Fasting plasma glucose or postload plasma glucose * Microalbuminuria and albumin-creatinine ratio * Glucose tolerance test * Follow up each 3 year with all the above measurements

Interventions

None listed

Sponsors

Aristotle University Of Thessaloniki
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All age \>50 volunteers

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Cardiovascular mortality10 years

Secondary

MeasureTime frame
Hospitalization for CV events10 years

Contacts

Primary ContactVasilios Kotsis, Prof
vkotsis@auth.gr6974748860

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026